Literature DB >> 27405053

Risk of developmental delay: Comparison of late preterm and full term Canadian infants at age 12 months.

Marilyn Ballantyne1, Karen M Benzies2, Sheila McDonald3, Joyce Magill-Evans4, Suzanne Tough5.   

Abstract

BACKGROUND: Late preterm (34(0/7) to 36(6/7)weeks gestation) infants may experience developmental delays greater than those found in term (≥ 37(0/7)weeks gestation) infants. AIM: The aim of this study was to compare the risk of developmental delay between late preterm and full-term Canadian born infants at age 12months, and to determine infant and maternal factors associated with risk of delay.
METHODS: A descriptive comparative study was conducted from data available from the All Our Babies community-based, prospective, pregnancy cohort in Calgary, Alberta. Participants were a sample of mothers of 52 infants born late preterm and 156 randomly selected mothers of term infants, matched for infant sex; eligible infants were singleton births. Mothers completed a developmental screening tool, the Ages and Stages Questionnaire, version 3 (ASQ-3), when their infant was age 12months. Corrected age (CA) was used for preterm infants.
RESULTS: Both late preterm and term infants who required neonatal intensive care (NICU) were more likely to demonstrate risk of developmental delay. Compared to term infants, there was a trend for late preterm infants to be at risk of communication and gross motor delay at age 12months CA that was attenuated to the null when adjustments were made for NICU admission and other covariates.
CONCLUSIONS: Infants born between 34 and 41weeks who are admitted to NICU are at increased risk of developmental delay. Early identification of risk provides an opportunity for referral for developmental assessment and early intervention programming.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27405053     DOI: 10.1016/j.earlhumdev.2016.04.004

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  7 in total

1.  Neurobehavior in very preterm infants with low medical risk and full-term infants.

Authors:  Roberta Pineda; Lara Liszka; Pido Tran; Jenny Kwon; Terrie Inder
Journal:  J Perinatol       Date:  2022-06-18       Impact factor: 3.225

2.  Exclusive Breastfeeding Duration and Perceptions of Infant Sleep: The Mediating Role of Postpartum Anxiety.

Authors:  Siân M Davies; Bethany F Todd-Leonida; Victoria M Fallon; Sergio A Silverio
Journal:  Int J Environ Res Public Health       Date:  2022-04-08       Impact factor: 4.614

3.  The Effect of a Social-Emotional Intervention on the Development of Preterm Infants in Institutions.

Authors:  Daria I Chernego; Robert B McCall; Shannon B Wanless; Christina J Groark; Marina J Vasilyeva; Oleg I Palmov; Natalia V Nikiforova; Rifkat J Muhamedrahimov
Journal:  Infants Young Child       Date:  2018-01-01

Review 4.  Early Neurological Assessment and Long-Term Neuromotor Outcomes in Late Preterm Infants: A Critical Review.

Authors:  Domenico M Romeo; Martina Ricci; Maria Picilli; Benedetta Foti; Giorgia Cordaro; Eugenio Mercuri
Journal:  Medicina (Kaunas)       Date:  2020-09-15       Impact factor: 2.430

5.  A Birth Cohort Study of Neurodevelopmental Outcomes from Birth to 2 Years of Age in Preterm Infants under 34 Weeks of Gestation.

Authors:  Hui-Li Li; Ling-Ling Chen; Gang Qian; Wei-Shi Wang; Xiao-Na Feng; Mei-Qiao Yu; Lu-Zhong Ren
Journal:  J Healthc Eng       Date:  2022-04-13       Impact factor: 3.822

6.  Developmental Dimensions in Preterm Infants During the 1st Year of Life: The Influence of Severity of Prematurity and Maternal Generalized Anxiety.

Authors:  Erica Neri; Federica Genova; Fiorella Monti; Elena Trombini; Augusto Biasini; Marcello Stella; Francesca Agostini
Journal:  Front Psychol       Date:  2020-03-27

7.  Effects of Alberta Family Integrated Care (FICare) on Preterm Infant Development: Two Studies at 2 Months and between 6 and 24 Months Corrected Age.

Authors:  Amanda M Moe; Jana Kurilova; Arfan R Afzal; Karen M Benzies
Journal:  J Clin Med       Date:  2022-03-18       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.